Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Jan 15, 2026 · Filed Jan 21, 2026
The boss of Exponent sold $121K of Exponent shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$120,594
Shares × reported transaction price
77 days after results of Oct 30, 2025, 21 days before results of Feb 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Filing box checked: sold under a Rule 10b5-1 plan
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.9% | +1.5% | −3.4% |
| 30 days | −6.4% | +0.6% | −7.0% |
| 90 days | −8.9% | +2.7% | −11.6% |
| 180 days | −16.4% | +8.3% | −24.6% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
CEO sold ~$149K of Exponent, Inc.
Automatic saleDerivative exercise or conversion — not an open-market buy.